News UK pharma hopes more doctors will disclose industry payments Almost a year after launch, ABPI is confident more doctors will disclose payments
News Countdown to European pharma transparency begins EFPIA's Disclosure Code will come into force on June 30.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
